Healius (HLS) TRADING HALT SUSPENDED

20mins delayed

Movement

1 Year Return

System message

20 June 2019: Highest Dividend Yield stocks and ASX Broker Consensus scans updated. Join my email list to get notified.

Healius Chart

Share price
Last
Change
Volume
Turnover
Market Cap $1.92 billion
Today's Movement
Prev. Close
Open
Day Range -
VWAP
Historical Stats
52w Range -
4w Avg Volume
4w Avg Turnover
(delayed)

HLS Statistics

26 June

168 / 2,323

ASX Size Rank

1yr Return

vs Sector (1yr)

-19.30%

vs ASX 200 (1yr)

-16.67%

$1.92 billion

Market Cap

Share Issue

622.32 million

All Ords (%)

0.09%

Short Sold

1.9%

Current Fundamentals

26 June

309

PE Ratio

EPS ($)

0.01

Earnings Yield

0.32%

NTA ($)

-1.05

3.01%

Dividend Yield

DPS ($)

0.093

Gross Div. Yield

4.30%

Gross DPS ($)

0.1328

Company Overview

Healius Limited (HLS, formerly Primary Health Care Limited) is a healthcare company providing service to medical and health professionals through its network of medical centres and pathology centres across Australia. HLS is also a provider of healthcare technology solutions to medical practitioners, medical practices and hospitals.

Former Names
Primary Health Care Limited (PRY), 04/12/2018

Healius Logo

Corporate Details

Head Office: St Leonards
Managing Director: Malcolm Parmenter
GICS Sub-Industry: Health Care Services
Date Listed: 3 Jul 1998
Registry: Computershare
Similar Companies: RHC / SHL / HSO / EBO / PRY

Upcoming Calendar

19 Aug 2019 Report (Prelim)
27 Sep 2019 Report (Annual)
14 Feb 2020 Report (Interim)

Dividend History

Ex-Date Amount Franking Type Payable
15/03/2019 $0.038 100% Interim 26/03/2019
27/08/2018 $0.055 100% Final 17/09/2018

See Upcoming Dividends for all ASX companies.

Announcements

Date Heading Pages File Size Time

Broker Consensus

The buy, hold and sell recommendations from Australian stockbroking firms are combined to form a "broker consensus". See the Consensus Data posts for more information.

BUY

20/06/19

5

BUY

6

HOLD

0

SELL

Broker Consensus data compiled by Market Index.

Directors & Management

About the Data


Name Title Since Bio
Mr David M Richwhite Non-Executive Director Aug 2018
Mr Robert Hubbard Non-Executive Director, Non-Executive Chairman Dec 2014
Dr Malcolm Parmenter Chief Executive Officer, Managing Director Sep 2017
Ms Arlene May Tansey Non-Executive Director Aug 2012
Mr Gordon Richard Davis Non-Executive Director Aug 2015
Dr Paul Francis Jones Non-Executive Director Nov 2010
Dr Errol Katz Non-Executive Director Nov 2010
Ms Sally Evans Non-Executive Director Aug 2018
Maxine Jaquet Chief Executive Health & Co N/A
Dean Lewsam Chief Executive Imaging N/A
Timothy Haggett Chief Executive Medical Centres N/A
Wesley Lawrence Chief Executive Pathology N/A
Malcolm Ashcroft Chief Financial Officer N/A
Charles Tilley Company Secretary N/A

SHOW ALL

Director Transactions

About the Data

HLS directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
21/12/18 Errol Katz Buy +13,080 $2.250 $29,430 On-market trade.
27/11/18 Arlene Tansey Buy +4,000 $2.520 $10,080 On-market trade.
12/10/18 Malcolm Parmenter Issued 527,178 $2.820 $1,486,641 Issue of securities.
14/09/18 Arlene Tansey Issued 1,920 $2.500 $4,800 Rights issue.
14/09/18 Robert Hubbard Issued 5,951 $2.500 $14,877 Rights issue.
14/09/18 Malcolm Parmenter Issued 9,597 $2.500 $23,992 Rights issue.
14/09/18 Gordon Davis Issued 5,759 $2.500 $14,397 Rights issue.
14/09/18 Paul Jones Issued 6,536 $2.500 $16,340 Rights issue.
14/09/18 Errol Katz Issued 1,920 $2.500 $4,800 Rights issue.
31/08/18 Robert Hubbard Buy +15,000 $2.790 $41,850 On-market trade.
31/08/18 Gordon Davis Buy +20,000 $2.717 $54,334 On-market trade.
19/02/18 Paul Jones Buy +2,400 $3.800 $9,120 On-market trade.

SHOW ALL

Shareholder Distribution

About the Data

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001 and over Total Shareholders
No. of Shareholders 3,876 6,670 2,159 1,290 77 14,072

Top 20 Shareholders

About the Data

Name Shares Capital
HSBC Custody Nominees (Australia) Limited 171,103,309 29.28%
J P Morgan Nominees Australia Limited 114,493,564 19.59%
Jangho Health Care Australia Pty Limited 83,139,070 14.23%
National Nominees Limited 49,986,250 8.55%
Citicorp Nominees Pty Limited 30,684,982 5.25%
BNP Paribas Noms Pty Ltd 11,632,679 1.99%
Argo Investments Limited 9,307,750 1.59%
CS Third Nominees Pty Limited 6,828,794 1.17%
CS Fourth Nominees Pty Limited 6,102,777 1.04%
BNP Paribas Nominees Pty Ltd 4,328,246 0.74%
Citicorp Nominees Pty Limited 2,757,440 0.47%
HSBC Custody Nominees (Australia) Limited GSCO ECA 2,505,364 0.43%
HSBC Custody Nominees (Australia) Limited 2,158,327 0.37%
Rinrim Pty Limited 1,962,000 0.34%
Bainpro Nominees Pty Limited 1,930,448 0.33%
Charado Pty Ltd 1,235,488 0.21%
AMP Life Limited 1,117,374 0.19%
Warbont Nominees Pty Ltd 1,065,230 0.18%
National Nominees Limited 973,000 0.17%
Nulis Nominees (Australia) Limited 962,831 0.16%
All other shareholders 13.72 %

SHOW ALL

The Top 20 Shareholders of HLS hold 86.28% of shares on issue.

HLS Share Price History

Date Close Change % Change Open High Low Volume Turnover
FULL MONTH LAST 5 DAYS

HLS Historical Data

Download up to 20 years of share price history.

DOWNLOAD CSV

Year Closing Price (30 June) Last Trade

Offical data as published by ASX. See more Data Downloads.

Company Details

Principal Activity: A medical centre operator; a provider of diagnostic imaging services; a provider of pathology; and a provider of health technology.

Incorporated: Incorporated on 17 May 1994 in Victoria, Australia.

Level 6, 203 Pacific Hwy
St Leonards NSW 2065

www.primaryhealthcare.com.au


All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.